Mutation Analysis of the TGFBI Gene in Consecutive Korean Patients With Corneal Dystrophies
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Mutations in the transforming growth factor β-induced gene (TGFBI) are major causes of genetic corneal dystrophies (CDs), which can be grouped into TGFBI CDs. Although a few studies have reported the clinical and genetic features of Korean patients with TGFBI CD, no data are available regarding the frequency and spectrum of TGFBI mutations in a consecutive series of Korean patients with clinically diagnosed CDs. Methods: Patients with any type of CD, who underwent both ophthalmologic examination and TGFBI gene analysis by Sanger sequencing at a tertiary care hospital in Seoul, Korea from 2006 to 2013, were enrolled in this study. Results: Among a total of 89 patients, 77 (86.5%) were diagnosed as having clinical TGFBI CD. Seventy-three out of 74 patients (98.6%) with granular CD type 2 (GCD2), had the p.R124H mutation. Of particular note, one patient with rapidly progressive CD had the p.R124H mutation as well as a novel nonsense variant with unknown clinical significance (p.A179*). In three patients with lattice CD type 1 (LCD1), one known mutation (p.R124C) and two novel variants (p.L569Q and p.T621P) in the TGFBI gene were identified. Conclusions: This study provides epidemiological insight into CDs in a Korean population and reaffirms that GCD2 is the most common TGFBI CD phenotype and that p.R124H is the only mutation identified in patients with GCD2. In addition, we broaden the spectrum of TGFBI mutations by identifying two novel missense variants in patients with LCD1.
Abstract
Background: Mutations in the transforming growth factor β-induced gene (TGFBI) are major causes of genetic corneal dystrophies (CDs), which can be grouped into TGFBI CDs. Although a few studies have reported the clinical and genetic features of Korean patients with TGFBI CD, no data are available regarding the frequency and spectrum of TGFBI mutations in a consecutive series of Korean patients with clinically diagnosed CDs. Methods: Patients with any type of CD, who underwent both ophthalmologic examination and TGFBI gene analysis by Sanger sequencing at a tertiary care hospital in Seoul, Korea from 2006 to 2013, were enrolled in this study. Results: Among a total of 89 patients, 77 (86.5%) were diagnosed as having clinical TGFBI CD. Seventy-three out of 74 patients (98.6%) with granular CD type 2 (GCD2), had the p.R124H mutation. Of particular note, one patient with rapidly progressive CD had the p.R124H mutation as well as a novel nonsense variant with unknown clinical significance (p.A179*). In three patients with lattice CD type 1 (LCD1), one known mutation (p.R124C) and two novel variants (p.L569Q and p.T621P) in the TGFBI gene were identified. Conclusions: This study provides epidemiological insight into CDs in a Korean population and reaffirms that GCD2 is the most common TGFBI CD phenotype and that p.R124H is the only mutation identified in patients with GCD2. In addition, we broaden the spectrum of TGFBI mutations by identifying two novel missense variants in patients with LCD1.
참고문헌 (17)
- Zhang T, "Molecular genetics of Chinese families with TGFBI corneal dystrophies", Mol Vis, 17, pp.380~387 (2011)
- Klintworth GK, "Corneal dystrophies", Orphanet J Rare Dis, 4, pp.7~ (2009)
- Weiss JS, "The IC3D classification of the corneal dystrophies", Cornea, 27(Suppl 2), pp.S1~83 (2008)
- Zhu Y, "The TGFBI R555W mutation induces a new granular corneal dystrophy type I phenotype", Mol Vis, 17, pp.225~230 (2011)
- Abazi Z, "Individual phenotypic variances in a family with Avellino corneal dystrophy", BMC Ophthalmol, 13, pp.30~ (2013)
- Aldave AJ, "Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet?", Arch Ophthalmol, 125, pp.177~186 (2007)
- Nowinska AK, "Genotype-phenotype correlation of TGFBI corneal dystrophies in Polish patients", Mol Vis, 17, pp.2333~2342 (2011)
- Yoshida S, "Lattice corneal dystrophy type I without typical lattice lines: role of mutational analysis", Am J Ophthalmol, 137, pp.586~588 (2004)
- Kim HS, "BIGH3 gene mutations and rapid detection in Korean patients with corneal dystrophy", Cornea, 20, pp.844~849 (2001)
- Jun RM, "Avellino corneal dystrophy after LASIK", Ophthalmology, 111, pp.463~468 (2004)
- Lee JH, "Prevalence of granular corneal dystrophy type 2 (Avellino corneal dystrophy) in the Korean population.", Ophthalmic Epidemiol, 17, pp.160~165 (2010)
- Cho KJ, "TGFBI gene mutations in a Korean population with corneal dystrophy", Mol Vis, 18, pp.2012~2021 (2012)
- Han KE, "Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature", Eye Contact Lens, 36, pp.296~299 (2010)
- Holland EJ, "Avellino corneal dystrophy. Clinical manifestations and natural history", Ophthalmology, 99, pp.1564~1568 (1992)
- Yam GH, "In vitro amyloid aggregate forming ability of TGFBI mutants that cause corneal dystrophies", Invest Ophthalmol Vis Sci, 53, pp.5890~5898 (2012)
- Vincent AL, "TGFBI mutational analysis in a New Zealand population of inherited corneal dystrophy patients", Br J Ophthalmol, 94, pp.836~842 (2010)
- Sakimoto T, "A novel nonsense mutation with a compound heterozygous mutation in TGFBI gene in lattice corneal dystrophy type I", Jpn J Ophthalmol, 47, pp.13~17 (2003)